Massachusetts Institute of Technology Massachusetts Institute of Technology
Department of Chemical Engineering
Langer Lab
Symposium Chairmen
Abstract Submission
Hotel Information
Related Events

9th US - Japan Symposium on Drug Delivery Systems

December 16 - 20, 2007

Sunday, December 16
2:30 - 5:30 p.m   Registration
5:45 – 6:55 p.m   Welcome Reception
Evening Session
7:00 p.m. 


Robert Langer and Yasuhiko Tabata 
Discussion Leader: Rodney Pearlman
8:30-9:00 p.m. Coffee Break  
Juichi Ito
Professor, Kyoto University
A strategy for treatment of inner ear diseases using new drug delivery system
John Santini  
President & Chief Executive Officer, MicroCHIPS, Inc.
Programmable drug delivery from implantable multi-reservoir devices
Paul Burke
Executive Director, Pharmaceutics & Drug Delivery, Amgen
Delivery enhanced biopharmaceuticals: Overcoming barriers to commercialization

Bob Miller
Vice President Polymer Chemistry, Genzyme Drug & Biomaterial R & D
Properties of Chemically Modified Hyaluronan and Other Macromolecules

Monday, December 17
Morning Session
7:00 - 8:00 a.m.   Registration
8:30 a.m.     
Discussion Leader:  Nicholas Peppas  
10:45-11:15 a.m. Coffee Break  

Hideyuki Okano
Professor, Keio University School of Medicine
Novel therapeutic strategies for CNS-repair

Henry Brem
Professor, Johns Hopkins School of Medicine
Advances in brain tumor therapy

Mari Dezawa
Associate Professor, Kyoto University
Bone marrow stromal cells for auto-cell transplantation therapy:  Applications for neuro- and muscle-degenerative diseases

Colin R. Gardner
Senior Vice President, Research & Site Head, TransForm Pharmaceuticals, Inc. (a J&J company)
Materials science impact on formulation design and performance
Larry Sternson
Chief Executive Officer, Avidimer Therapeutics
Dendrimers as nanomolecular platforms for targeted therapeutics
Afternoon: Unscheduled
Evening Sessions
7:30 p.m.      
Discussion Leader: Masatoshi Chiba  
8:50-9:10 p.m. Refreshment Break  
John Patton
Founder & Chief Scientific Officer, Nektar Therapeutics
New pulmonary and pegylation advances
Mitsuru Hashida
Professor, Kyoto University 
Yuriko Higuchi
Researcher, Kyoto University
Development of ligand modified quantum dots for imaging
Jeffrey Carbeck
Chief Technology Officer, WMR Biomedical, Inc.
In vivo printing of biomaterials
Tuesday, December 18
Morning Session
8:30 a.m.       
Discussion Leader:   Yutaka Hirai  
10:30-11:00 a.m. Coffee Break   
Atushi Maeda
Senior Manager, Astellas Pharma, Inc.
Study on enzymatic cleavable polymer coated long-circulating liposome system
Gerald Bernstein
Vice President, Medical Affairs, Director, Generex Biotechnology Corp
Buccal delivery of drugs for diabetes
Yasuhiro Matsumura
Chief, Investigative Treatment Division, National Cancer Center Hospital East
Micelle carrier system in cancer chemotherapy
Jeremy Heidel
Vice President, Research and Development and Chief Scientific Officer, Calando Pharmaceuticals
Targeted siRNA-containing formulations for clinical, systemic application
Hideyoshi Harashima 
Professor, Hokkaido University
In vivo siRNA delivery with MEND
Afternoon: Unscheduled
Evening Session #1
7:30 p.m – 9:30 p.m.    Oral Presentation of Posters - Selected from Poster
Discussion Leader:  Michael Sefton  
 8:30 p.m. Refreshment Break  
Wednesday, December 19
Morning Session
8:30 a.m.    
Discussion Leader: Tsuneji Nagai and Yasuhiko Tabata

10:30-11:00 a.m. Coffee Break  
Akihiko Sano
Senior Manager, Dainippon Sumitomo Pharma Co., Ltd.
Atelocollagen-mediated technology as an effective drug delivery system for nucleic drugs
Akihiko Sano
Senior Manager, Dainippon Sumitomo Pharma Co., Ltd.
Atelocollagen-mediated technology as an effective drug delivery system for nucleic drugs
Gary Cleary
President & Chief Technology Officer, Corium International, Inc.
Advances in transdermal drug delivery using microporation
Glenn Batchelder
Chief Executive Officer, BIND Biosciences, Inc.
Targeted nanoparticles for therapeutic applications
Howard Rosen
Vice President, Commercial Strategy, Gilead Sciences, Inc.
What’s new in cystic fibrosis therapy
Mitsuru Akashi
Professor, Osaka University
Self-organizing nano-biomaterials:  Nano-particles and nano-films
Afternoon: Unscheduled

Evening Session: Special session honoring Joseph Robinson

7:30 p.m.    
Discussion Leader:  Sung Wan Kim  
8:50 p.m. Refreshment Break  
Min Young Lee
Vice President, Sam Yang Corporation
Launch of Genexol-PM with bio-polymers increasing therapeutic index (tentative)
Francis Szoka
Professor of Biopharmaceutical Sciences, University of California, San Francisco
New molecules for lipid based drug delivery
John Siebert
Chairman & Chief Executive Officer, CyDex, Inc.
Unique Pharmaceutical solubilization examples; Unique product differentiation 
Thursday, December 20
Morning Session    
8:30 a.m.     
Discussion Leader:  Bruce Zetter  
10:30-11:00 a.m. Coffee Break  
Yasufumi Kaneda
Professor, Osaka University
Development of virosome-based drug delivery systems for cancer therapy
Thomas Schluep
Chief Scientific Officer, Insert Therapeutics, Inc.
Cyclodextrin polymer nanoparticles for cancer therapy:  New molecules and first clinical results
Hikaru Sugihara
Ono Pharmaceutical Co., Ltd.
A new platform for gastric retentive system as a sustained release formulation
Joachim Kohn
Professor, Rutgers University
Combinatorial discovery approaches accelerate the development of drug eluting combination devices
Afternoon: Unscheduled
Evening Session    
7:30 p.m.   Oral Presentation of Posters - Selected from Poster Session #2  
Discussion Leader Alexander Klibanov  
8:30 p.m. Refreshment Break  


Langer Lab, 77 Massachusetts Ave, Room 76-661, Cambridge, MA 02139-4307 | Phone: 617.253.3123 | Last updated: January 7, 2011